← SynDRA
Dalargin
SynDRA canonical compound SYN2055838 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | OPRM1 |
| Mechanism of action | Opioid receptor agonist |
All known targets
Mechanisms of action (all sources)
Drug classes
- Adjuvants, Immunologic
- Analgesics
- Anti-Arrhythmia Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Anti-Ulcer Agents
- Antioxidants
- Gastrointestinal Agents
- Sympatholytics
Cross-references
Synonyms
- Enkephalin-leu, ala(2)-arg(6)-
- 2-Ala-6-Arg-Leu-enkephalin
- V13505565P
- 1-6-beta-Neoendorphin (human), 2-D-alanine-
- Tyr-Ala-Gly-Phe-Leu-Arg
- Leu-enkephalin, Ala(2)-Arg(6)-
- leucine-enkephalin, Ala(2)-Arg(6)-
- enkephalin, Ala(2)-Leu(5)-Arg(6)-
- enkephalin-Leu, alanyl(2)-arginine(6)-
- RefChem:130772
- tyrosyl-alanyl-glycyl-phenylalanyl--leucyl-arginine
- DTXCID10153793
- (D-Ala2)-Leu-Enkephalin-Arg
- Tyr-D-Ala-Gly-Phe-Leu-Arg
- tageflar
- Tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine
- UNII-V13505565P
- DALARGINE
- BRN 4287455
- (D-Ala2)-Leu-Enkephalin-Arg acetate salt
- 2-D-Alanine-1-6-beta-neoendorphin (human)
- DALARGIN [WHO-DD]
- orb1744198
- SCHEMBL29374920
- SCHEMBL29657682
- 1-6-(D-ALA2)-DYNORPHIN
- EX-A5715
- HY-P4053
- AC-38383
- FA108952
- CS-0635584
- T73404
- 1-6-.BETA.-NEOENDORPHIN (HUMAN), 2-D-ALANINE-
- L-tyrosyl-D-alanylglycyl-L-phenylalanyl-L-leucyl-L-arginine
- H-DL-Tyr-Ala-Gly-DL-Phe-DL-Leu-D-Arg-OH
- SCHEMBL26689635
- BRD-A89196962-300-01-7
- (D-ALA2)-LEUCINEENKEPHALIN-ARG
Look up Dalargin in the interactive SynDRA portal →